R&D
Done Differently
Accelerating the Global Development of Innovative Biopharmaceutical Products
Drug Development is a Journey
Let’s get there together.
We are a clinical-stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with difficult-to-treat diseases, beginning with cancers. We seek to utilize our team’s deep drug development experience to maximize the potential of our lead development candidate, firmonertinib (previously known as furmonertinib), and advance a pipeline of novel oncology therapeutics, such as next-generation antibody drug conjugates, through approval and commercialization. We forge strategic collaborations and work closely with our partners as we develop these medicines that otherwise may not reach global populations.